STOCK TITAN

Humana Stock Price, News & Analysis

HUM NYSE

Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.

Humana Inc. (HUM) is a leading health insurance provider specializing in government-sponsored healthcare programs and integrated wellness solutions. This dedicated news hub provides investors and industry professionals with timely updates on corporate developments, financial performance, and strategic initiatives shaping the healthcare sector.

Access authoritative information through verified press releases covering earnings announcements, Medicare Advantage plan expansions, Medicaid service updates, and partnerships in primary care innovation. Track regulatory filings related to prescription drug plans and pharmacy benefit management services critical to HUM's operations.

Key updates include insights into value-based care models, military health program (TRICARE) enhancements, and advancements in at-home healthcare services. All content is sourced directly from company communications to ensure accuracy for financial analysis and market trend evaluation.

Bookmark this page for streamlined access to HUM's latest operational milestones and healthcare industry leadership updates. Check regularly for objective reporting on developments impacting one of America's largest managed care organizations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.82%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.02%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.45%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.12%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
partnership
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.39%
Tags
conferences
-
Rhea-AI Summary

Humana Inc. (HUM) reported strong 1Q23 earnings with a GAAP EPS of $9.87, up from $7.29 in 1Q22. Adjusted EPS rose to $9.38 from $7.81, driven by robust membership growth in the individual Medicare Advantage sector, which is projected to grow by at least 775,000 members, a 17% increase year-over-year. The company raised its FY 2023 EPS guidance to 'at least $27.88' on a GAAP basis and 'at least $28.25' adjusted. Total revenues for 1Q23 reached $26.74 billion, up from $23.97 billion a year earlier, supported by favorable inpatient utilization trends. Humana's operating cash flow showed significant improvement, reaching $6.69 billion, largely due to adjustments in premium payment timings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.75%
Tags
Rhea-AI Summary

Humana Inc. (NYSE: HUM) has declared a cash dividend of $0.885 per share, scheduled for payment on July 28, 2023, to shareholders of record as of the close of business on June 30, 2023. This dividend reflects the company's commitment to returning value to its shareholders while supporting its mission to improve healthcare for its members. Humana continues to focus on integrated care solutions, including in-home services and data analytics, which aim to enhance health outcomes and reduce costs. The company remains dedicated to its diverse members, including those in Medicare and military service.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.53%
Tags
dividends

FAQ

What is the current stock price of Humana (HUM)?

The current stock price of Humana (HUM) is $247.34 as of May 19, 2025.

What is the market cap of Humana (HUM)?

The market cap of Humana (HUM) is approximately 30.5B.
Humana

NYSE:HUM

HUM Rankings

HUM Stock Data

30.52B
120.40M
0.2%
97.78%
3.03%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
LOUISVILLE